Global RNA Analysis/Transcriptomics Market Analysis Report 2019 by Application (Clinical Diagnostics, Drug Discovery, Toxicogenomics)

RNA Analysis/Transcriptomics Market by Technology (Microarray, PCR,
NGS, RNAi), by Application (Clinical Diagnostics, Drug Discovery,
Toxicogenomics), by End-User (Academic Research, Pharmaceutical and
Biotech Companies) - Global Forecast to 2019
By
MarketsandMarkets
Published: September2014
No. of Pages: 300
Single User License: US$ 4650
Corporate User License: US$ 7150
Order this report by calling
+1 888 391 5441 or Send an email
to sales@reportsandreports.com
with your contact details and
questions if any.
1© ReportsnReports.com / Contact sales@reportsandreports.com

RNA Analysis/Transcriptomics Market by Technology, by
Application, by End-User - Global Forecast to 2019
New Market Research Report on “RNA Analysis/Transcriptomics Market by
Technology (Microarray, PCR, NGS, RNAi), by Application (Clinical Diagnostics, Drug
Discovery, Toxicogenomics), by End-User (Academic Research, Pharmaceutical and
Biotech Companies) - Global Forecast to 2019”adds to ReportsnReports.com.
The global Transcriptomics Market is expected to grow at a CAGR of 13.7% during the
forecast period of 2014 to 2019 and is estimated to be worth $3,773.0 million by
2019. The transcriptomics market has blatantly grown in the past few years primarily
due to the increasing technological advancements in the field of sequencing
technologies in transcriptomics research. Similarly, the increasing government and
private funding for research coupled with research and development investments by
the biotechnology companies are expected to drive the transcriptomics market. The
increasing adoption of transcriptomics in the field of biomarker discovery opens new
growth avenues with the rising preference of personalized medicine across the globe.
However, the higher investment costs that restrict the adoption of transcriptomics
products and dearth of skilled professionals are the factors hampering the growth of
this market to a certain extent.
Order this report by calling +1 888 391 5441 or Send an email to
sales@reportsandreports.com with your contact details and questions if any.

The transcriptomics market report covers the transcriptomic technologies, applications
and end-users. The technologies market in this report is segmented as microarray, PCR,
sequencing technologies which include Sanger sequencing and NGS, and RNAi gene
silencing technology. Each of these technologies market is further sub-segmented into
reagents, instruments and software. The applications of transcriptomics covered under
the scope of this report are clinical diagnostics, drug discovery, and toxicogenomics. The
end-users of transcriptomics are pharmaceutical and biotechnology companies, academic
research and government institutes, and hospitals and diagnostic centers. This report also
discusses the key market drivers, restraints, opportunities, challenges, and trends in the
global transcriptomics market and its submarkets.
Complete report available @ http://www.reportsnreports.com/reports/298661-rna-
analysis-transcriptomics-market-by-technology-microarray-pcr-ngs-rnai-by-application-
clinical-diagnostics-drug-discovery-toxicogenomics-by-end-user-academic-research-
pharmaceutical-and-biotech-companies-global-forecast-to-2019.html

By 2019, North America will continue to dominate and drive the transcriptomics market,
primarily due to the rising preference for personalized medicines which use biomarkers
developed with the transcriptomic technologies. On the other hand, the market in Asia-
Pacific region is expected to grow at a highest CAGR during the forecast period mainly
due to the growing pharmaceutical and biotech industries in China and India. The
reduction in funding for research and development coupled with decrease in the
investment in research by the pharmaceutical and biotechnology companies in the
European region as a means of cost containment is expected to hamper the growth of
transcriptomics market in Europe.
The prominent players in the global trancriptomics market are Affymetrix Inc. (U.S.),
Agilent Technologies Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), GE Healthcare (U.S.),
Illumina Inc. (U.S.), Qiagen N.V. (Germany), F. Hoffmann-La Roche Ltd. (Switzerland),
Sigma Aldrich (U.S.), Fluidigm Corporation (U.S.), and Thermofisher Scientific Inc. (U.S.).

Table of Contents
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Industry Trends
7 Transcriptomics Technologies Market, By
Type
8 Global Transcriptomics Market, By
Application
9 Global Transcriptomics Market, By End User
Inquire for discount on this report @
http://www.reportsnreports.com/contacts/Discount.aspx?name=298661 .
10 Global Transcriptomics Market, By
Geography
11 Company Profiles
11.1 Affymetrix Inc.
11.2 Agilent Technologies, Inc.
11.3 Bio-Rad Laboratories, Inc.
11.4 GE Healthcare
11.5 Illumina, Inc.
11.6 Qiagen N.V.
11.7 F. Hoffmann-La Roche Ltd.
11.8 Sigma-Aldrich Corporation
11.9 Thermo Fisher Scientific, Inc.
11.10 Fluidigm Corporation
12 Competitive Landscape
13 Appendix

ReportsnReports.com is your single source for all market research needs. Our database
includes 350,000+ syndicated market research reports from 100+ leading global
publishers covering in-depth analysis of over 5000 micro markets. With comprehensive
information about the publishers and their report methodology, data sources, etc. we
help you in your purchase decision by mapping your information needs with the most
relevant available reports in our library. Join us on social platforms to keep yourself
updated about the latest market intelligence for industry of your interest.

Global RNA Analysis/Transcriptomics Market Analysis Report 2019 by Application (Clinical Diagnostics, Drug Discovery, Toxicogenomics)

Recommended

Recommended

More Related Content

Recently uploaded

Recently uploaded (20)

Featured

Featured (20)

Global RNA Analysis/Transcriptomics Market Analysis Report 2019 by Application (Clinical Diagnostics, Drug Discovery, Toxicogenomics)